A detailed history of Truvestments Capital LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 2,057 shares of CRL stock, worth $408,170. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,057
Previous 1,648 24.82%
Holding current value
$408,170
Previous $446,000 4.93%
% of portfolio
0.17%
Previous 0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $84,413 - $109,910
409 Added 24.82%
2,057 $424,000
Q1 2024

May 14, 2024

BUY
$203.52 - $273.43 $335,400 - $450,612
1,648 New
1,648 $446,000
Q2 2022

Aug 09, 2022

BUY
$204.13 - $302.4 $1,633 - $2,419
8 New
8 $2,000
Q1 2019

Apr 12, 2019

SELL
$104.82 - $146.73 $4,716 - $6,602
-45 Closed
0 $0
Q3 2018

Oct 22, 2018

BUY
$112.11 - $134.54 $5,044 - $6,054
45 New
45 $6,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.